Kuros Biosciences AG Stock
Stocks
KURN
CH0325814116
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Swiss Exchange
11:30:11 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 20.30 CHF | -0.29% |
|
+20.83% | -26.13% |
| 10-15 | Kuros Biosciences AG Raises Group Earnings Guidance for the Full Year 2026 | CI |
| 10-15 | Kuros Biosciences Lifts FY26 Group Sales Growth Guidance | MT |
| Market Cap | 807M 978M 874M 731M 1.37B 92.87B 1.39B 9.71B 3.85B 48.66B 3.67B 3.59B 153B | P/E 2026 * |
88.6x | P/E 2027 * | 43.6x |
|---|---|---|---|---|---|
| Enterprise Value | 801M 971M 867M 726M 1.36B 92.15B 1.38B 9.64B 3.82B 48.28B 3.64B 3.57B 152B | EV / Sales 2026 * |
4.71x | EV / Sales 2027 * | 3.56x |
| Free-Float |
65.72% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Swiss Exchange
| KURN | Delayed | |
CBOE
| 0RHR | Real-time | |
London S.E.
| 0RHR | Delayed | |
OTC Markets
| CSBTF | Delayed | |
Boerse Muenchen
| YTSN | Real-time | |
Tradegate
| YTSN | Real-time | |
Deutsche Boerse AG
| YTSN | Delayed | |
Börse Stuttgart
| YTSN | Delayed | |
Xetra
| YTSN | Delayed |
Last Transcript: Kuros Biosciences AG
| 1 day | -0.29% | ||
| 1 week | +20.83% | ||
| Current month | +10.99% | ||
| 1 month | +18.16% | ||
| 3 months | +2.53% | ||
| 6 months | -7.89% | ||
| Current year | -26.13% |
| 1 week | 16.52 | 20.88 | |
| 1 month | 16.52 | 20.88 | |
| Current year | 16.46 | 30.3 | |
| 1 year | 16.46 | 32.48 | |
| 3 years | 2.46 | 34.2 | |
| 5 years | 1.11 | 34.2 | |
| 10 years | 1.11 | 34.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Christopher Fair
CEO | Chief Executive Officer | 56 | 2023-10-11 |
Joost de Bruijn
CEO | Chief Executive Officer | 60 | 2017-12-03 |
Daniel Geiger
DFI | Director of Finance/CFO | - | 2023-02-16 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | 2018-06-13 | |
Joost de Bruijn
BRD | Director/Board Member | 60 | 2018-06-13 |
Oliver Walker
BRD | Director/Board Member | 57 | 2018-06-13 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/26/26 | Sell | -7,225 | 0.0184% | |||
| 12/13/25 | Sell | 30,000 | 0.0766% | |||
| 12/8/25 | Sell | 30,000 | 0.0766% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.29% | +20.83% | -31.88% | +712.00% | 978M | ||
| +2.41% | +0.29% | +39.41% | +72.14% | 64.69B | ||
| -0.15% | +7.50% | +11.42% | +71.27% | 54.78B | ||
| +0.57% | +4.60% | +7.71% | +90.93% | 53.49B | ||
| +0.37% | +4.67% | +26.68% | +49.64% | 45.98B | ||
| -1.21% | +2.32% | +21.50% | +118.33% | 42.94B | ||
| -0.37% | +5.07% | +243.23% | +789.58% | 40.08B | ||
| +0.05% | +0.21% | +18.06% | +48.50% | 33.52B | ||
| +1.19% | -4.98% | +26.31% | -0.76% | 23.97B | ||
| -0.38% | +5.68% | +38.39% | +28.35% | 23.67B | ||
| Average | +0.22% | +4.26% | +40.08% | +198.00% | 38.41B | |
| Weighted average by Cap. | +0.39% | +2.78% | +45.82% | +144.29% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 170M 206M 184M 154M 288M 19.56B 293M 2.05B 810M 10.25B 773M 757M 32.32B | 220M 267M 238M 199M 373M 25.32B 379M 2.65B 1.05B 13.27B 1B 980M 41.83B |
| Net income | 9.21M 11.16M 9.97M 8.35M 15.61M 1.06B 15.87M 111M 43.87M 555M 41.89M 41M 1.75B | 20.27M 24.57M 21.95M 18.37M 34.37M 2.33B 34.94M 244M 96.59M 1.22B 92.23M 90.26M 3.85B |
| Net Debt | -6.24M -7.57M -6.76M -5.66M -10.59M -718M -10.76M -75.13M -29.75M -376M -28.4M -27.8M -1.19B | -23.4M -28.36M -25.33M -21.2M -39.67M -2.69B -40.32M -282M -111M -1.41B -106M -104M -4.45B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-23 | CHF 20.30 | -0.29% | 226,675 |
| 26-10-22 | CHF 20.36 | +4.73% | 330,021 |
| 26-10-21 | CHF 19.44 | +3.79% | 404,624 |
| 26-10-20 | CHF 18.73 | +11.16% | 425,432 |
| 26-10-19 | CHF 16.85 | +0.30% | 366,274 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- KURN Stock
Select your edition
All financial news and data tailored to specific country editions

















